Evidence Hub

Polymyxin B Therapy-Induced Respiratory Arrest in a Liver Donor: A Case Report

D. Navakanth

CASE report, 2025

Abstract

Polymyxin B is a potent antibiotic used in multi-drug resistant (MDR) gram-negative infections. It is a known nephrotoxic and neurotoxic drug with serious side effects. Respiratory paralysis is very rarely seen with polymyxin B therapy, with only a few cases reported worldwide. We report a case of a young liver donor who developed respiratory arrest after receiving intravenous (IV) polymyxin B, required intubation, and mechanical ventilatory support. The patient regained full consciousness within an hour. After reviewing literature, we found that polymyxins can cause such side effects. Polymyxin B was discontinued, and she was extubated the following day. With the emergence of MDR organisms, the use of polymyxin B has increased tremendously. This case highlights the importance of closely monitoring patients who are administered such potent antibiotics

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free